Thursday, September 23, 2010

Would you trade your heart for normal blood sugars?

The increased risk of heart attack is one of the biggest incentives for diabetics to closely monitor and control their blood sugars. So why would you want to take any medication that makes it more likely that you'll have a heart attack, even if it does do a good job of lowering your sugars?

That's what I don't understand about why the FDA has chosen to keep Avandia on the market. The increased risk of heart attack is documented, so why would they allow the company to continue selling the drug, even if it is on a more restricted basis?

I wouldn't be surprised if someone is pressuring the FDA to keep the drug on the market...

No comments: